Clover (ASX:CLV) Interest Expense (Positive)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:CLV Clover Corp Ltd ASX:CLV
60 GF Score
Price A$0.85
GF Value A$0.76
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Clover Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.

ASX:CLV
60GF Score
Clover Corp Ltd ASX:CLV
Interest Expense (Positive) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clover (ASX:CLV) Overvalued in 2026?

Based on GuruFocus' analysis, Clover stock appears to be overvalued. The current stock price of A$0.85 is trading 11.8% above its estimated GF Value™ of A$0.76. GuruFocus considers Clover to be Modestly Overvalued.

Key valuation signals for ASX:CLV:

  • Interest Expense (Positive):
  • GF Value™: A$0.76 vs. price of A$0.85 (11.8% above fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the ASX:CLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clover Business Description

Address 39 Pinnacle Road, Altona North, Melbourne, VIC, AUS, 3025
Clover Corp Ltd provides nutritional and functional ingredients. The company is involved in the production of encapsulated powders, and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; and Ocean Gold refined tuna oils. Its products include DHA oils, DHA powders, and Microencapsulation. Geographically, the group has a business presence in Australia, New Zealand, Asia, Europe and the Americas. Majority of the revenue is derived from Australia/New Zealand.
60GF Score

Get the complete analysis for ASX:CLV

Interest Expense (Positive) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.85
Price
A$0.76
GF Value